Clinical trials
Completed Phase 2 trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
335 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 13 |
| 2007 | 15 |
| 2008 | 16 |
| 2009 | 17 |
| 2010 | 15 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 20 |
| 2014 | 13 |
| 2015 | 23 |
| 2016 | 16 |
| 2017 | 15 |
| 2018 | 26 |
| 2019 | 22 |
| 2020 | 16 |
| 2021 | 21 |
| 2022 | 25 |
| 2023 | 14 |
| 2024 | 9 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 335 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 58 |
| Hoffmann-La Roche | 27 |
| Sanofi | 24 |
| Merck Sharp & Dohme LLC | 16 |
| Bayer | 12 |
| Eli Lilly and Company | 12 |
| AstraZeneca | 11 |
| Janssen Research & Development, LLC | 11 |
| Pfizer | 11 |
| Novo Nordisk A/S | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Asthma | 13 |
| COVID-19 | 10 |
| Multiple Myeloma | 10 |
| Renal Insufficiency, Chronic | 9 |
| Anemia, Sickle Cell | 8 |
| Non-alcoholic Fatty Liver Disease | 8 |
| Stomach Neoplasms | 8 |
| Pulmonary Disease, Chronic Obstructive | 7 |
Trials
Showing 1 to 25 of 335. Each trial links to its page on Pharma Observatory.
235 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.